O. Dalesio

771 total citations
25 papers, 607 citations indexed

About

O. Dalesio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, O. Dalesio has authored 25 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in O. Dalesio's work include Cancer Treatment and Pharmacology (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Treatments and Mutations (5 papers). O. Dalesio is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Treatments and Mutations (5 papers). O. Dalesio collaborates with scholars based in Netherlands, Belgium and Italy. O. Dalesio's co-authors include Harry Bleiberg, N. Duez, J. Wils, Herbert M. Pinedo, Nico van Zandwijk, Giuseppe Giaccone, T. A. W. Splinter, Manon Huizing, Alexandre Roussel and Marc Buyse and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

O. Dalesio

25 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Dalesio Netherlands	12	325	312	237	79	53	25	607
Rocco De Vivo Italy	14	172 0.5×	166 0.5×	109 0.5×	78 1.0×	74 1.4×	27	429
J H Jacob France	14	504 1.6×	473 1.5×	508 2.1×	103 1.3×	26 0.5×	27	915
Ka On Lam Hong Kong	13	171 0.5×	210 0.7×	122 0.5×	48 0.6×	13 0.2×	40	501
Mao-Chih Hsieh Taiwan	16	453 1.4×	181 0.6×	342 1.4×	69 0.9×	39 0.7×	29	752
Jane E. Latz United States	14	447 1.4×	391 1.3×	51 0.2×	131 1.7×	44 0.8×	28	664
Yvonne Lassere United States	14	320 1.0×	761 2.4×	205 0.9×	146 1.8×	45 0.8×	20	887
Hajime Yokomizo Japan	12	129 0.4×	282 0.9×	241 1.0×	59 0.7×	50 0.9×	121	512
E Piana Italy	11	340 1.0×	390 1.3×	109 0.5×	67 0.8×	8 0.2×	28	592
Hongfu Cai China	13	181 0.6×	266 0.9×	144 0.6×	31 0.4×	43 0.8×	52	430
C. Sessa Switzerland	10	91 0.3×	203 0.7×	106 0.4×	122 1.5×	26 0.5×	26	447

Countries citing papers authored by O. Dalesio

Since Specialization

Citations

This map shows the geographic impact of O. Dalesio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Dalesio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Dalesio more than expected).

Fields of papers citing papers by O. Dalesio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Dalesio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Dalesio. The network helps show where O. Dalesio may publish in the future.

Co-authorship network of co-authors of O. Dalesio

This figure shows the co-authorship network connecting the top 25 collaborators of O. Dalesio. A scholar is included among the top collaborators of O. Dalesio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Dalesio. O. Dalesio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pető, Richárd & O. Dalesio. (2003). 328 Breast and prostate cancer: 10-year survival gains in the hormonal adjuvant treatment trials. European Journal of Cancer Supplements. 1(5). S101–S101. 10 indexed citations

Vermorken, Jan B., C. Mangioni, S. Pecorelli, et al.. (2000). Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 10(5). 358–365. 6 indexed citations

Huizing, Manon, Giuseppe Giaccone, Laurence J. van Warmerdam, et al.. (1997). Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.. Journal of Clinical Oncology. 15(1). 317–329. 159 indexed citations

Veenhof, C.H.N., Manon Huizing, Sjoerd Rodenhuis, et al.. (1997). Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding study.. PubMed. 24(1 Suppl 2). S2–31. 14 indexed citations

Giaccone, Giuseppe, Manon Huizing, Pieter E. Postmus, et al.. (1996). Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer. Lung Cancer. 14(1). 171–171. 27 indexed citations

Zandwijk, Nico van & O. Dalesio. (1995). Platinum-based chemotherapy in non-small cell lung cancer: The experience of the European Organization for the Research and Treatment of Cancer. Lung Cancer. 12(1-2). 146–146. 4 indexed citations

Planting, A.S.T., T. A. W. Splinter, Andrea Ardizzoni, et al.. (1992). Phase II study of ACNU as second-line treatment in small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 29(5). 409–411. 7 indexed citations

Dalesio, O., Sjoerd Rodenhuis, R. Dubbelman, et al.. (1992). Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.. PubMed. 19(1 Suppl 2). 99–101. 10 indexed citations

Planting, A.S.T., Andrea Ardizzoni, Giuseppe Giaccone, et al.. (1991). Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872. Cancer Chemotherapy and Pharmacology. 28(2). 145–146. 5 indexed citations

10.

Schwartsmann, Gilberto, J. Wanders, H. R. Franklin, et al.. (1991). EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents. European Journal of Cancer and Clinical Oncology. 27(9). 1162–1168. 21 indexed citations

11.

Giaccone, Giuseppe, et al.. (1991). Cisplatin and etoposide for locally advanced or metastatic thymoma. A phase II study of the EORTC lung cancer cooperative group. Lung Cancer. 7. 135–135. 1 indexed citations

12.

Durrant, K.R., C. Mangioni, A.J. Lacave, et al.. (1990). Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: A phase II study of the EORTC gynaecological cancer cooperative group (GCCG). Gynecologic Oncology. 37(3). 359–362. 37 indexed citations

13.

Villani, Claudio, et al.. (1990). Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study.. PubMed. 11(5). 323–30. 8 indexed citations

14.

Jortay, A, F Démard, O. Dalesio, et al.. (1990). A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years.. PubMed. 90(3). 115–22. 24 indexed citations

15.

Roussel, Alexandre, Harry Bleiberg, O. Dalesio, et al.. (1989). Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: Final results of a controlled clinical trial. International Journal of Radiation Oncology*Biology*Physics. 16(1). 67–72. 32 indexed citations

16.

Bleiberg, Harry, O. Dalesio, Marc Buyse, et al.. (1989). Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC.. PubMed. 15(6). 535–43. 55 indexed citations

17.

Gignoux, M, Alexandre Roussel, B Paillot, et al.. (1988). The Value of Preoperative Radiotherapy in Esophageal Cancer: Results of a Study by the EORTC. Recent results in cancer research. 110. 1–13. 39 indexed citations

18.

Wils, J., Harry Bleiberg, O. Dalesio, et al.. (1987). An EORTC gastrointestinal group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas. European Journal of Cancer and Clinical Oncology. 23(7). 1017–1018. 8 indexed citations

19.

Lacave, Ángel J., J. Wils, Harry Bleiberg, et al.. (1987). An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.. Journal of Clinical Oncology. 5(9). 1387–1393. 19 indexed citations

20.

Splinter, T. A. W., et al.. (1986). A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer.. PubMed. 13(3 Suppl 3). 97–103. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact